REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/09/2026
Back to search
Official data from USPTO
IMMUNOVIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOVIA
ST13
US500000079176585Class
5, 9, 10, 42, 44
Filing
79176585
Registration
5197689
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
05/10/2026
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
08/25/2015
Registration date
05/09/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/04/2024
Last transaction
05/10/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Lund, SE
Examiner
PEETE, KYLE C
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Immunovia AB
Immunovia AB
Representatives
Anuj Desai Arnall Golden Gregory LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Sanitary preparations for medical use; biological indicators for medical diagnosis; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical reagents for medical purposes for the diagnosis of cancer and auto-immune diseases
Class 9
Computer software for diagnosis of disease; computer software for diagnosing of cancer diseases; computer software for diagnosing of pancreatic cancer; computer software for diagnosing of breast cancer; computer software for diagnosing of prostate cancer; computer software for diagnosing of auto-immune diseases; DNA chips
Class 10
Medical apparatus and instruments for diagnosticprognostic patient stratificationexamination and monitoring purposesapparatus for multiplex measuring of proteins in blood; diagnostic apparatus for medical purposes for diagnosing cancer and auto-immune diseases; sensor apparatus for medical use in diagnosis for diagnosing cancer and auto-immune diseases; apparatus for carrying-out diagnostic tests for medical purposes for diagnosing cancer and auto-immune diseases; medical diagnostic apparatus for detecting cancer and auto-immune diseases; DNA microarray for use in medical research for medical purposes for the diagnosis of cancer and auto-immune diseases; blood testing analyzers for medical purposes for the diagnosis of cancer and auto-immune diseases
Class 42
Medical research services; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the area of pancreatic cancerous diseases; scientific research for medical purposes in the area of breast cancerous diseases; scientific research for medical purposes in the area of prostate cancerous diseases; scientific research for medical purposes in the area of auto-immune diseases; providing computer aided medical testing servicescomputer aided blood analysis services in the field of cancer and auto-immune diseases research; research and development of computer software
Class 44
Performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; performing diagnosis of cancer and auto-immune diseases
Publications
History of USPTO decisions and trademark events.
46 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/25/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/18/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/28/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/28/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/28/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/28/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/28/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/04/2024
71AG
REGISTERED-SEC.71 ACCEPTED
01/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/03/2024
ES71
TEAS SECTION 71 RECEIVED
05/04/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/09/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/20/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/11/2017
FIMP
FINAL DISPOSITION PROCESSED
08/11/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/09/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/05/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/19/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/19/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2017
PUBO
PUBLISHED FOR OPPOSITION
02/21/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/16/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/16/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/16/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/16/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/16/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/16/2016
GNFR
FINAL REFUSAL E-MAILED
07/16/2016
CNFR
FINAL REFUSAL WRITTEN
07/16/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/14/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/14/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2016
RFNP
REFUSAL PROCESSED BY IB
01/04/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/15/2015
RFRR
REFUSAL PROCESSED BY MPU
12/15/2015
MAFR
APPLICATION FILING RECEIPT MAILED
12/15/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/12/2015
CNRT
NON-FINAL ACTION WRITTEN
12/11/2015
DOCK
ASSIGNED TO EXAMINER
12/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/04/2015
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOVIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.